Copyright
©The Author(s) 2022.
World J Clin Cases. Feb 6, 2022; 10(4): 1286-1290
Published online Feb 6, 2022. doi: 10.12998/wjcc.v10.i4.1286
Published online Feb 6, 2022. doi: 10.12998/wjcc.v10.i4.1286
Table 1 The changes in hemoglobin, reticulocytes and IgG during the 24 mo of follow-up
| Indicator | Baseline | M1 | M3 | M5 | M12 | M18 | M24 |
| Hb (g/L) | 105 | 132 | 155 | 150 | 139 | 148 | 134 |
| RET (%) | 4.9 | 1.6 | 1.2 | 1.0 | 1.2 | 0.9 | 0.9 |
| IgG (g/L) | 46.71 | 23.47 | 15.33 | 14.2 | 13.22 | 15.53 | 12.29 |
- Citation: Zhang J, Wang X, Tian JJ, Zhu R, Duo RX, Huang YC, Shen HL. Iguratimod in treatment of primary Sjögren’s syndrome concomitant with autoimmune hemolytic anemia: A case report. World J Clin Cases 2022; 10(4): 1286-1290
- URL: https://www.wjgnet.com/2307-8960/full/v10/i4/1286.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i4.1286